Meibomian Gland Loss and Dysfunction in Mild versus Moderate-Severe Thyroid Eye Disease
Journal of Current Ophthalmology · 2024-04 · 36 (2) · 145-151
DOI: 10.4103/joco.joco_176_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Ophthalmology, online erschienen am 18.01.2025. Verfasst von Hossein Aghaei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Purpose
To compare meibomian gland (MG) loss and MG dysfunction (MGD) in patients with mild versus moderate-severe thyroid eye disease (TED).
Methods
Consecutive patients with TED and no other causes of dry eye disease underwent meibography and meiboscore of each eyelid were graded as 0 (no MG loss), 1 (66% loss), with a total score of 0–6. MG expression score (0–3), eyelid margin signs of MGD, lipid layer thickness (LLT), ocular surface disease index (OSDI), tear secretion, noninvasive tear break-up time (NITBUT), and tear meniscus height (TMH) were also assessed by a masked observer.
Results
Included were 21 eyes (21 patients) with mild and 19 eyes (19 patients) with moderate-severe TED. The two groups were not different except for a higher frequency of smoking ( P < 0.01). Eyes with moderate-severe TED showed a higher upper eyelid meiboscore ( P = 0.03), MG expression score ( P < 0.01), and tear film osmolality ( P = 0.02) as well as lower LLT ( P = 0.03). Total meiboscore had a significantly positive correlation with OSDI (r s = 0.37) and tear film osmolality (r s = 0.50) as well as a negative correlation with NITBUT (r s = −0.55), TMH (r s = −0.44), and LLT (r s = −0.38). While older age, male gender, smoking, and longer duration of disease were significantly associated with the higher (≥3) meiboscore in univariate analysis, none remained significant in multivariate analysis.
Conclusion
MG loss and MGD were significantly more severe in moderate-severe than mild TED.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
- Department of Ophthalmology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
- Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Zitieren
APA
Aghaei, H., Zarastvand, F., Abdolalizadeh, P., Karimi, N., Es'haghi, A., Clark, J. D., Compton, C. J., West, N. L., & Kashkouli, M. B. (2024). Meibomian Gland Loss and Dysfunction in Mild versus Moderate-Severe Thyroid Eye Disease. Journal of Current Ophthalmology, 36(2), 145-151. https://doi.org/10.4103/joco.joco_176_23
Vancouver
Aghaei H, Zarastvand F, Abdolalizadeh P, Karimi N, Es'haghi A, Clark JD, et al. Meibomian Gland Loss and Dysfunction in Mild versus Moderate-Severe Thyroid Eye Disease. Journal of Current Ophthalmology. 2024;36(2):145-151. doi:10.4103/joco.joco_176_23
BibTeX
@article{Aghaei2024,
author = {Aghaei, Hossein and Zarastvand, Fatemeh and Abdolalizadeh, Parya and Karimi, Nasser and Es'haghi, Acieh and Clark, Jeremy D and Compton, Christopher J and West, Nicole L and Kashkouli, Mohsen Bahmani},
title = {Meibomian Gland Loss and Dysfunction in Mild versus Moderate-Severe Thyroid Eye Disease},
journal = {Journal of Current Ophthalmology},
year = {2024},
volume = {36},
number = {2},
pages = {145--151},
doi = {10.4103/joco.joco_176_23}
}
EUVIMED